SRM-Ⅳ前庭功能诊疗系统对儿童良性阵发性位置性眩晕的治疗效果

Application of SRM-Ⅳvestibular functional diagnosis and treatment system on benign paroxysmal positional vertigo in children

目的探讨SRM-Ⅳ前庭功能诊疗系统对儿童良性阵发性位置性眩晕(BPPV)的治疗效果。方法回顾性分析2018-06至2022-06联勤保障部队第989医院眩晕门诊收治的21例BPPV患儿的临床资料,对其治疗效果、不良反应进行分析,并对12个月内不同时间随访结果进行分析。结果21例中,首次治疗总有效率61.9%,3次治疗后有效率达100.0%。随访12个月,复发2例。治疗后有5例(23.8%)发生不良反应:3例表现为活动时或活动后出现头晕,持续5~11 d;2例活动后出现自身晃动感,分别持续9 d和15 d,均自行缓解。结论SRM-Ⅳ前庭功能诊疗系统治疗儿童BPPV效果显著,复发率低。

Objective To explore the diagnostic and therapeutic effects of SRM-Ⅳvestibular functional diagnosis and treatment system on benign paroxysmal positional vertigo(BPPV)in children.Methods The clinical data of 21 children with BPPV diagnosed in the Dizziness Outpatient Department of the 989 Hospital of PLA Joint Logistic Support Force from June 2018 to June 2022 were retrospectively analyzed.The therapeutic effects and adverse reactions were compared and analyzed,and the follow-up results were analyzed at different time within 12 months.Results Among the 21 cases,the totol effective rate was 61.9%after the first treatment and 100.0%after the third treatment.During the 12 months of follow-up,2 cases relapsed.After treatment,5 cases(23.8%)had adverse reactions,among which three cases showed dizziness during or after activity,lasting for 5 two 11 days,and two cases experienced their own shaking sensation after activity,lasting for 9 and 15 days respectively,and all the 5 cases were relieved by themselves.Conclusions SRM-Ⅳvestibular functional diagnosis and treatment system is effective in the treatment of BPPV in children,and the recurrence rate is low.